⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Cook MyoSite, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Cook MyoSite, Inc.
↗Pittsburgh, USA
Cook MyoSite, a subsidiary of the Cook Group, is a biotechnology company dedicated to the development and commercialization of autologous muscle-derived cell therapies for regenerative medicine. Founded in 2002, the company leverages its proprietary muscle cell technology to address various muscle-related disorders and unmet medical needs.
The company operates with a focus on rigorous clinical research and quality standards, maintaining ISO9001:2015 certification for its laboratory research services. Cook MyoSite is actively involved in clinical trials and strategic partnerships to advance its pipeline, which includes therapies for conditions such as fecal incontinence and oropharyngeal dysphagia.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Regenerative Medicine / Cell Therapy
SIZE & FINANCIALS
Employees:51-200
Founded:2002
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3
Modalities:Cell therapy, Autologous muscle-derived cells
Active Trials:14
Trial Phases:Phase 3: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Cook Group
Key Partnerships:Veristat (CRO for Phase III DigniFI Study), Curi Bio (Strategic collaboration for 3D tissue models), UC Davis Health (Clinical research partnership)
COMPETITION
Position:Niche Player
Competitors:Mesoblast, BrainStorm Cell Therapeutics, Bluebird Bio
LEADERSHIP
Key Executives:
Ryan Pruchnic - Managing Vice President
Ron Jankowski - Vice President of Regulatory and Scientific Affairs
LINKS
Website:cookmyosite.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cook MyoSite, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.